Better Glycemic Control with Once-Weekly Insulin Icodec vs. Once-Daily Insulin Degludec in Insulin-Naïve Type 2 Diabetes (ONWARDS 3)
In this medfyle
In insulin-naive type 2 diabetes, once-weekly icodec is associated with greater HbA1c reduction compared to once-daily degludec after 26 weeks. There was no difference in weight and a higher rate of combined level 2 or 3 hypoglycemic events with once-weekly icodec in the context of less than 1 event per patient-year exposure in both groups.
About this Medfyle
This content is intended for an international audience of non-UK healthcare professionals. The content is made available through a licensing agreement between Infomedica and the American Diabetes Association (ADA).
The information and data provided is for information purposes only. The presenting author(s) of the original presentation had no involvement in the creation of this content. The viewpoints expressed may not represent Infomedica, Medfyle, or the ADA.
©2023 Infomedica-Medfyle. All rights reserved.
